User Manual

Lumax Technical Manual 127
 A strategy of care using BIOTRONIK Home Monitoring with
office visits when needed has been shown to extend the time
between routine, scheduled in-office follow-ups of
BIOTRONIK implantable devices in many patients. Home
Monitoring data is helpful in determining the need for
additional in-office follow-up.
 BIOTRONIK Home Monitoring-patients—who are followed
remotely with office visits when needed—have been shown to
have similar numbers of strokes, invasive procedures and
deaths as patients followed with conventional in-office
follow-ups.
 BIOTRONIK Home Monitoring provides early detection of
arrhythmias.
 BIOTRONIK Home Monitoring provides early detection of
silent, asymptomatic arrhythmias.
 Automatic early detection of arrhythmias and device system
anomalies by BIOTRONIK Home Monitoring allows for earlier
intervention than conventional in-office follow-ups.
 BIOTRONIK Home Monitoring allows for improved access to
patient device data compared to conventional in-office
follow-ups since device interrogation is automatically
scheduled at regular intervals.
The implant’s Home Monitoring function can be used for the
entire operational life of the implant (prior to EOS) or for shorter
periods, such as several weeks or months. Home Monitoring is
programmable, ON or OFF.
NOTE:
When ERI mode is reached, this status is transmitted. All
measurements and transmissions are unaffected. When End
of Service (EOS) is reached and transmitted, further
measurements and transmissions of Home Monitoring data
are no longer possible.